Add BrightSurf on Google Email

Science News for May 3, 2015


Gene therapy efficacy for LCA: Improvement is followed by decline in vision

A new study demonstrates that gene therapy for Leber congenital amaurosis (LCA) improves vision in patients within weeks of treatment, with benefits peaking at one to three years after treatment. However, the visual gain eventually declines, highlighting the need for future therapeutic strategies to sustain restored vision.

SourceUniversity of Pennsylvania School of Medicine·JournalNew England Journal of Medicine·DateMay 3, 2015